Pharmacological signatures of the reduced incidence and the progression of cognitive decline in ageing populations suggest the protective role of beneficial polypharmacy-Reference-Cited by-同舟云学术

Pharmacological signatures of the reduced incidence and the progression of cognitive decline in ageing populations suggest the protective role of beneficial polypharmacy

Published:2019-11-06 Issue:11 Volume:14 Page:e0224315
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mayburd Anatoly L.^ORCID,Koivogui Mathilda,Baranova Ancha

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference80 articles.

1. Updated Alzheimer’s Statistics report. The Alzheimer’s Association Facts and Figure (2019). https://www.alz.org/news/2019/new-alzheimer-s-association-report

2. RAND Corporation, press release. Cost of Dementia Tops $159 Billion Annually in the United States (2013). https://www.rand.org/news/press/2013/04/03.html.

3. Prevalence of dementia in the United States: the aging, demographics, and memory study;BL Plassman;Neuroepidemiology,2007

4. A comparison of the prevalence of dementia in the United States in 2000 and 2012;KM Langa;JAMA internal medicine,2017

5. Alzheimer’s Disease and Related Clinical Trials (2019). https://www.nia.nih.gov/alzheimers/clinical-trials/search

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline Profiles of Drug Prescriptions Prior to Diagnosis of Mild Cognitive Impairment (MCI) Obtained by Latent Class Analysis (LCA), and Assessment of Their Association with Conversion to Dementia;Healthcare;2023-08-07

2. New opportunities for treatment of neurodegenerative disease through the modulation of TDP-43;TDP-43 and Neurodegeneration;2022

3. Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer’s Disease;Journal of Alzheimer's Disease Reports;2021-11-23

4. Towards Appropriate Prescribing for Older Persons with Multiple Chronic Conditions;Archives of Gerontology and Geriatrics;2021-05

5. Probiotics, prebiotics, and synbiotics for the treatment of dementia;Medicine;2020-01